South Korean medical imaging AI company Neurophet has received second clearance for its brain image analysis software in the United States.
It obtained another 510(k) from the US Food and Drug Administration for the latest functionality on Neurophet Aqua that analyses multiple sclerosis and white matter hyperintensities using T2-FLAIR images.
The brain MRI scan-based analysis software, which...
Lunit collabs with AstraZeneca, secures major deal in France
Lunit and AstraZeneca have partnered to develop new AI-powered digital pathology solutions that predict non-small cell lung cancer (NSCLC).
Based on a media release, their collaboration aims to accelerate the time-consuming process of genomic testing as part of NSCLC identification and diagnosis by leveraging Lunit's AI. The latter's...
Neurophet sets up China JV
Medical imaging AI company Neurophet from South Korea has established a joint venture in China.
It recently signed an exclusive deal with LADO, one of the leading medical software providers in China, to market its AI-based software for quantifying levels of Alzheimer's disease biomarkers in PET images.
The deal, which also establishes a joint venture with LADO, aims...
Mental health app Lissun bags $3M for AI integration
Mental health platform Lissun in India has scored $2.5 million in a pre-Series A funding round led by RPSG Capital Ventures.
With its fresh funds, the startup plans to integrate AI into its suite of digital mental health solutions which target corporates, schools, and families of children with neurodevelopmental conditions. The new funds will...
Neurophet AI to integrate with upcoming Alzheimer's treatment device
Neurophet has entered into a partnership with ReadyCure for the development of a dementia treatment system called Helaxon.
Based on a press statement, Neurophet will be integrating its AI solution, Neurophet AQUA, to support brain image analysis in Helaxon. The AI-based software can analyse and detect white matter degeneration...
Neurophet scores $15M in Series C funding, announces 2024 IPO
South Korean company Neurophet, a provider of brain image analysis software, has raised 20 billion won ($15 million) in a Series C funding round participated by institutional investors, such as KB Securities, Mirae Asset Securities, and IBK Industrial Bank of Korea.
This brings its total investments since its founding in 2016 to 50...
South Korean health tech company Neurophet has obtained certification from Singapore's Health Sciences Authority for its AI-enabled degenerative brain disease diagnosis assistant software.
Its flagship software, Neurophet Aqua, analyses brain MRI using AI to check for brain atrophy and white matter degeneration as seen in neurodegenerative diseases such as Alzheimer's disease and vascular...
Dozee scores 510(k) for AI contactless sensor for RPM
Indian medical device company Dozee has received the United States Food and Drug Administration's 510(k) clearance for its proprietary contactless sensor for remote patient monitoring.
The Dozee sensor sheet, which is placed under a hospital bed mattress, captures micro-vibrations from patients using Ballistocardiography. These vibrations are...
